Bristol Myers Squibb (BMY) Return on Sales (2016 - 2025)
Bristol Myers Squibb (BMY) has disclosed Return on Sales for 17 consecutive years, with 0.09% as the latest value for Q4 2025.
- On a quarterly basis, Return on Sales rose 8.0% to 0.09% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.15%, a 33.0% increase, with the full-year FY2025 number at 0.15%, up 33.0% from a year prior.
- Return on Sales was 0.09% for Q4 2025 at Bristol Myers Squibb, down from 0.18% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.22% in Q1 2025 to a low of 1.0% in Q1 2024.
- A 5-year average of 0.09% and a median of 0.14% in 2022 define the central range for Return on Sales.
- Peak YoY movement for Return on Sales: tumbled -120bps in 2024, then skyrocketed 122bps in 2025.
- Bristol Myers Squibb's Return on Sales stood at 0.2% in 2021, then fell by -10bps to 0.18% in 2022, then fell by -14bps to 0.15% in 2023, then crashed by -96bps to 0.01% in 2024, then soared by 1311bps to 0.09% in 2025.
- Per Business Quant, the three most recent readings for BMY's Return on Sales are 0.09% (Q4 2025), 0.18% (Q3 2025), and 0.11% (Q2 2025).